Page 137 - 《中国药房》2024年1期
P. 137
ischemia-reperfusion injury (MIRI)[J]. Biomater Sci, [14] ZHANG X Y,YU Y H,LEI H Y,et al. The Nrf-2/HO-1
2022,10(21):6258-6266. signaling axis:a ray of hope in cardiovascular diseases[J].
[ 2 ] YANG Y,MA M Q,SU J N,et al. Acetylation,ferropto‐ Cardiol Res Pract,2020,2020:5695723.
sis,and their potential relationships:implications in myo‐ [15] 蒋志明,张辽,刘磊,等. 电针心经激活核因子E2相关因
cardial ischemia-reperfusion injury[J]. Am J Med Sci, 子 2/血红素氧合酶信号通路抑制铁死亡改善急性心肌
2023,366(3):176-184. 缺血[J]. 针刺研究,2023,48(5):461-468.
[ 3 ] CHANG C,CAI R P,SU Y M,et al. Mesenchymal stem JIANG Z M,ZHANG L,LIU L,et al. Electroacupuncture
cell-derived exosomal noncoding RNAs as alternative improves ischemic myocardial injury by activating Nrf2/
treatments for myocardial ischemia-reperfusion injury: HO-1 signaling pathway to inhibit ferroptosis in rats[J].
current status and future perspectives[J]. J Cardiovasc Acupunct Res,2023,48(5):461-468.
Transl Res,2023,16(5):1085-1098. [16] XIA J Y,CHEN C,LIN Q,et al. Role of mitophagy in
[ 4 ] ZHANG Q,LIU J,DUAN H,et al. Activation of Nrf2/ myocardial ischemia/reperfusion injury and Chinese medi‐
HO-1 signaling:an important molecular mechanism of cine treatment[J]. Chin J Integr Med,2023,29(1):81-88.
herbal medicine in the treatment of atherosclerosis via the [17] 陈中青,侯丹丹,王伟 . 瑞芬太尼通过核因子 E2 相关因
protection of vascular endothelial cells from oxidative 子通路增强自噬改善大鼠心肌缺血再灌注损伤的研究
stress[J]. J Adv Res,2021,34:43-63. [J]. 中国临床药理学杂志,2023,39(1):47-51.
[ 5 ] LI S,YANG K,CAO W L,et al. Tanshinone ⅡA enhances CHEN Z Q,HOU D D,WANG W. Remifentanil against
the therapeutic efficacy of mesenchymal stem cells de‐ myocardial ischemia-reperfusion injury by enhancing au‐
rived exosomes in myocardial ischemia/reperfusion injury tophagy via the activation of nuclear factor erythroid 2-re‐
via up-regulating miR-223-5p[J]. J Control Release,2023, lated factor 2 pathway in rat model[J]. Chin J Clin Phar‐
358:13-26. macol,2023,39(1):47-51.
[ 6 ] WU Z Y,YANG Z X,LIU L Y,et al. Natural compounds [18] O’DONNELL A,PEPPER C,MITCHELL S,et al. NF-
protect against the pathogenesis of osteoarthritis by media- κB and the CLL microenvironment[J]. Front Oncol,2023,
ting the Nrf2/ARE signaling[J]. Front Pharmacol,2023, 13:1169397.
14:1188215. [19] ZHANG Z Y,YAN B F,LI Y G,et al. Propofol inhibits
[ 7 ] TONELLI C,CHIO I I C,TUVESON D A. Transcrip‐ oxidative stress injury through the glycogen synthase ki‐
tional regulation by Nrf2[J]. Antioxid Redox Signal,2018, nase 3 beta/nuclear factor erythroid 2-related factor 2/
29(17):1727-1745. heme oxygenase-1 signaling pathway[J]. Bioengineered,
[ 8 ] SANI G,MARGONI S,BRUGNAMI A,et al. The Nrf2 2022,13(1):1612-1625.
pathway in depressive disorders:a systematic review of [20] WANG R,WU Y G,JIANG S T. FOXC2 alleviates myo‐
animal and human studies[J]. Antioxidants,2023,12 cardial ischemia-reperfusion injury in rats through regula-
(4):817. ting Nrf2/HO-1 signaling pathway[J]. Dis Markers,2021,
[ 9 ] SONI D,KUMAR P. GSK-3β-mediated regulation of 2021:9628521.
Nrf2/HO-1 signaling as a new therapeutic approach in the [21] 董莉,杨燕玲,郑钰凡,等. 益心方调控SIRT1/PGC-1α信
treatment of movement disorders[J]. Pharmacol Rep, 号通路改善大鼠心肌缺血再灌注损伤[J]. 上海中医药杂
2022,74(4):557-569. 志,2023,57(7):58-65.
[10] LEAL E C,CARVALHO E. Heme oxygenase-1 as thera‐ DONG L,YANG Y L,ZHENG Y F,et al. Yixin formula
peutic target for diabetic foot ulcers[J]. Int J Mol Sci, modulates SIRT1/PGC-1α signaling pathway to improve
2022,23(19):12043. myocardial ischemia-reperfusion injury in rats[J]. Shanghai
[11] XU J J,ZHU K Y,WANG Y L,et al. The dual role and J Tradit Chin Med,2023,57(7):58-65.
mutual dependence of heme/HO-1/Bach1 axis in the carci‐ [22] 马艺华,石月萍 . 温阳通脉方通过 Nrf2/HO-1 通路对缺
nogenic and anti-carcinogenic intersection[J]. J Cancer 氧/复氧损伤H9c2心肌细胞氧化应激的保护作用[J]. 中
Res Clin Oncol,2023,149(1):483-501. 药药理与临床,2022,38(5):73-77.
[12] MANSOURI A,REINER Ž,RUSCICA M,et al. Antioxi‐ MA Y H,SHI Y P. Protective effect of Wenyang tongmai
dant effects of statins by modulating Nrf2 and Nrf2/HO-1 recipe on oxidative stress of H9c2 cardiomyocytes injured
signaling in different diseases[J]. J Clin Med,2022,11 by hypoxia/reoxygenation through Nrf2/HO-1 pathway[J].
(5):1313. Pharmacol Clin Chin Mater Med,2022,38(5):73-77.
[13] FENG S L,LI Y T,HUANG H H,et al. Isoorientin re‐ [23] 刘晓瑜,顾民华,徐煜凌,等 . 定心方Ⅰ号方通过调控
verses lung cancer drug resistance by promoting ferropto‐ GSK3β/Nrf2/HO-1 通路防治大鼠心肌缺血再灌注损伤
sis via the SIRT6/Nrf2/GPX4 signaling pathway[J]. Eur J 的机制研究[J]. 中药新药与临床药理,2020,31(11):
Pharmacol,2023,954:175853. 1265-1270.
中国药房 2024年第35卷第1期 China Pharmacy 2024 Vol. 35 No. 1 · 127 ·